NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/04/2023
Back to search
Official data from USPTO
ONKOCLONE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
07/04/2023
Trademark type
Word
Nice classes
44
Filing date
09/07/2022
Registration date
07/04/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/04/2023
Last transaction
07/04/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/23/2022
First use in commerce
10/23/2022
Drawing code
4
Owner type
16
Owner location
Elmwood Park, NJ, US
Examiner
CARR,PATRICK C
Law office
N70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
BioReference Health, LLC
Representatives
Arthur L. Lessler LESSLER & LESSLER
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Medical laboratory testing services for diagnostic or treatment purposes that enables DNAbased nextgeneration sequencing (NGS) testing to detect lymphoproliferative disorders and serve as molecular markers of malignant B or T cells
Publications
History of USPTO decisions and trademark events.
20 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/04/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/18/2023
PUBO
PUBLISHED FOR OPPOSITION
04/18/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/29/2023
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
03/14/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/12/2023
IUAA
USE AMENDMENT ACCEPTED
03/12/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/10/2023
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
02/10/2023
IUAF
USE AMENDMENT FILED
02/10/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/09/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/09/2023
EAAU
TEAS AMENDMENT OF USE RECEIVED
02/09/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/03/2023
GNRT
NON-FINAL ACTION E-MAILED
02/03/2023
CNRT
NON-FINAL ACTION WRITTEN
02/03/2023
DOCK
ASSIGNED TO EXAMINER
02/01/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/25/2022
NWAP
NEW APPLICATION ENTERED
09/10/2022
Continuous trademark protection
Get notified about every new filing that threatens ONKOCLONE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.